These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 1610692

  • 21. Antimicrobial activity of topical agents against Propionibacterium acnes: an in vitro study of clinical isolates from a hospital in Shanghai, China.
    Ma Y, Zhang N, Wu S, Huang H, Cao Y.
    Front Med; 2016 Dec; 10(4):517-521. PubMed ID: 27896620
    [Abstract] [Full Text] [Related]

  • 22. A Polycation Antimicrobial Peptide Mimic without Resistance Buildup against Propionibacterium Acnes.
    Nair SS, Zolotarskaya OY, Beckwith MJ, Ohman DE, Wynne KJ.
    Macromol Biosci; 2017 Sep; 17(9):. PubMed ID: 28605136
    [Abstract] [Full Text] [Related]

  • 23. In vivo antibacterial effects of tretinoin-clindamycin and clindamycin alone on Propionibacterium acnes with varying clindamycin minimum inhibitory.
    Leyden JJ.
    J Drugs Dermatol; 2012 Dec; 11(12):1434-8. PubMed ID: 23377513
    [Abstract] [Full Text] [Related]

  • 24. Inhibition of neutrophil chemotactic factor production in comedonal bacteria by subminimal inhibitory concentrations of erythromycin.
    Akamatsu H, Kurokawa I, Nishijima S, Asada Y.
    Dermatology; 1992 Dec; 185(1):41-3. PubMed ID: 1386264
    [Abstract] [Full Text] [Related]

  • 25. Effect of clindamycin, erythromycin, lincomycin, and tetracycline on growth and extracellular lipase production by propionibacteria in vitro.
    Unkles SE, Gemmell CG.
    Antimicrob Agents Chemother; 1982 Jan; 21(1):39-43. PubMed ID: 7081974
    [Abstract] [Full Text] [Related]

  • 26. Antibiotic sensitivity of comedonal Propionibacterium acnes.
    Guin JD, Huber DS, Gielerak PL.
    Acta Derm Venereol; 1979 Jan; 59(6):552-54. PubMed ID: 94223
    [Abstract] [Full Text] [Related]

  • 27. Effects of benzoyl peroxide and erythromycin alone and in combination against antibiotic-sensitive and -resistant skin bacteria from acne patients.
    Eady EA, Farmery MR, Ross JI, Cove JH, Cunliffe WJ.
    Br J Dermatol; 1994 Sep; 131(3):331-6. PubMed ID: 7918006
    [Abstract] [Full Text] [Related]

  • 28. In-vitro and in-vivo efficacy of zinc acetate against propionibacteria alone and in combination with erythromycin.
    Fluhr JW, Bösch B, Gloor M, Höffler U.
    Zentralbl Bakteriol; 1999 Oct; 289(4):445-56. PubMed ID: 10603662
    [Abstract] [Full Text] [Related]

  • 29. Antibiotic-resistant Propionibacterium acnes among acne patients in a regional skin centre in Hong Kong.
    Luk NM, Hui M, Lee HC, Fu LH, Liu ZH, Lam LY, Eastel M, Chan YK, Tang LS, Cheng TS, Siu FY, Ng SC, Lai YK, Ho KM.
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):31-6. PubMed ID: 22103749
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure.
    Eady EA, Cove JH, Holland KT, Cunliffe WJ.
    Br J Dermatol; 1989 Jul; 121(1):51-7. PubMed ID: 2527056
    [Abstract] [Full Text] [Related]

  • 32. A Multifactorial Comparison of Ternary Combinations of Essential Oils in Topical Preparations to Current Antibiotic Prescription Therapies for the Control of Acne Vulgaris-Associated Bacteria.
    Owen L, Grootveld M, Arroo R, Ruiz-Rodado V, Price P, Laird K.
    Phytother Res; 2017 Mar; 31(3):410-417. PubMed ID: 28124400
    [Abstract] [Full Text] [Related]

  • 33. Contribution to the interpretation of the occurrence of unsuccessful therapeutical results in acne vulgaris with topical erythromycin (Propionibact. acnes).
    Gloor M, Lamerz A, Franke-Hoffman M.
    Zentralbl Bakteriol A; 1981 Feb; 248(4):502-8. PubMed ID: 6452774
    [Abstract] [Full Text] [Related]

  • 34. Antibiotic susceptibility in prostate-derived Propionibacterium acnes isolates.
    Olsson J, Davidsson S, Unemo M, Mölling P, Andersson SO, Andrén O, Söderquist B, Sellin M, Elgh F.
    APMIS; 2012 Oct; 120(10):778-85. PubMed ID: 22958285
    [Abstract] [Full Text] [Related]

  • 35. Inhibitory effects of Euphorbia supina on Propionibacterium acnes-induced skin inflammation in vitro and in vivo.
    Lim HJ, Jeon YD, Kang SH, Shin MK, Lee KM, Jung SE, Cha JY, Lee HY, Kim BR, Hwang SW, Lee JH, Sugita T, Cho O, Myung H, Jin JS, Lee YM.
    BMC Complement Altern Med; 2018 Sep 27; 18(1):263. PubMed ID: 30261862
    [Abstract] [Full Text] [Related]

  • 36. Resistance to erythromycin and clindamycin in cutaneous propionibacteria is associated with mutations in 23S rRNA.
    Ross JI, Eady EA, Cove JH, Ratyal AH, Cunliffe WJ.
    Dermatology; 1998 Sep 27; 196(1):69-70. PubMed ID: 9557230
    [No Abstract] [Full Text] [Related]

  • 37. In vitro emergence of fluoroquinolone resistance in Cutibacterium (formerly Propionibacterium) acnes and molecular characterization of mutations in the gyrA gene.
    Takoudju EM, Guillouzouic A, Kambarev S, Pecorari F, Corvec S.
    Anaerobe; 2017 Oct 27; 47():194-200. PubMed ID: 28602804
    [Abstract] [Full Text] [Related]

  • 38. In vitro antibiotic susceptibility patterns of Propionibacterium acnes isolated from acne patients: an Egyptian university hospital-based study.
    Abdel Fattah NS, Darwish YW.
    J Eur Acad Dermatol Venereol; 2013 Dec 27; 27(12):1546-51. PubMed ID: 23279041
    [Abstract] [Full Text] [Related]

  • 39. In vitro emergence of rifampicin resistance in Propionibacterium acnes and molecular characterization of mutations in the rpoB gene.
    Furustrand Tafin U, Trampuz A, Corvec S.
    J Antimicrob Chemother; 2013 Mar 27; 68(3):523-8. PubMed ID: 23115111
    [Abstract] [Full Text] [Related]

  • 40. Antibiotic-resistant Propionibacterium acnes suppressed by a benzoyl peroxide cleanser 6%.
    Leyden JJ, Wortzman M, Baldwin EK.
    Cutis; 2008 Dec 27; 82(6):417-21. PubMed ID: 19181031
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.